Overview

A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

Status:
NOT_YET_RECRUITING

Trial end date:
2027-03-06

Target enrollment:

Participant gender:

Summary

The safety, tolerability, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics study of HEC169584 capsules in healthy subjects .

Phase:

PHASE1

Details

Lead Sponsor:

Sunshine Lake Pharma Co., Ltd.